Inventor
KAROW MARGARET
US74 patents
⚠️ This page may combine multiple inventors who share the name “KAROW MARGARET”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
34 patentsUS8043617B2Oct 25, 2011
Human antibodies to human IL-6 receptor
REGENERON PHARMA91 citations99
US7582298B2Sep 1, 2009
High affinity antibodies to human IL-6 receptor
REGENERON PHARMA390 citations99
US7396664B2Jul 8, 2008
VEGF-binding fusion proteins and nucleic acids encoding the same
REGENERON PHARMA171 citations99
US7666622B2Feb 23, 2010
Monomeric self-associating fusion polypeptides and therapeutic uses thereof
REGENERON PHARMA56 citations95
US10905109B2Feb 2, 2021
ADAM6 mice
REGENERON PHARMA10 citations94
US10694725B2Jun 30, 2020
ADAM6 mice
REGENERON PHARMA15 citations94
US10577430B2Mar 3, 2020
ADAM6 mice
REGENERON PHARMA15 citations94
US10072095B2Sep 11, 2018
ADAM6 mice
REGENERON PHARMA14 citations93
US9708635B2Jul 18, 2017
Methods of making a nucleic acid encoding a human variable region
REGENERON PHARMA9 citations93
US9388446B2Jul 12, 2016
Methods of producing hybrid antibodies
REGENERON PHARMA6 citations93
US9371553B2Jun 21, 2016
Genetically modified mice that produce hybrid antibodies
REGENERON PHARMA6 citations93
US9353394B2May 31, 2016
Methods of producing hybrid antibodies
REGENERON PHARMA6 citations93
US7083950B2Aug 1, 2006
High affinity fusion proteins and therapeutic and diagnostic methods for use
REGENERON PHARMA26 citations93
US9884916B2Feb 6, 2018
High affinity antibodies to human IL-6 receptor
REGENERON PHARMA13 citations92
US11559050B2Jan 24, 2023
Humanized non-human animals with restricted immunoglobulin heavy chain loci
REGENERON PHARMA4 citations86
US10905108B2Feb 2, 2021
ADAM6 mice
REGENERON PHARMA6 citations84
US10640800B2May 5, 2020
Mice that produce hybrid antibodies
REGENERON PHARMA4 citations84
US10542735B2Jan 28, 2020
Humanized non-human animals with restricted immunoglobulin heavy chain loci
REGENERON PHARMA6 citations84
US10526630B2Jan 7, 2020
Genetically modified mice that produce hybrid antibodies
REGENERON PHARMA3 citations84
US10378039B2Aug 13, 2019
Mouse embryonic stem cells comprising a hybrid heavy chain immunoglobulin locus
REGENERON PHARMA3 citations84
US10378040B2Aug 13, 2019
Mice that produce hybrid antibodies
REGENERON PHARMA4 citations84
US10378037B2Aug 13, 2019
Methods of making a nucleic acid encoding a human variable region
REGENERON PHARMA3 citations84
US10378038B2Aug 13, 2019
Mice that produce hybrid antibodies
REGENERON PHARMA3 citations84
US10227625B2Mar 12, 2019
Methods of modifying eukaryotic cells
REGENERON PHARMA3 citations84
US9528136B2Dec 27, 2016
Methods of modifying eukaryotic cells
REGENERON PHARMA5 citations84
US9382567B2Jul 5, 2016
Methods of producing hybrid antibodies
REGENERON PHARMA3 citations84
US9308256B2Apr 12, 2016
Method of treating rheumatoid arthritis with an anti-IL-6R antibody
REGENERON PHARMA11 citations84
US7459426B2Dec 2, 2008
Methods of using IL-1 antagonists to treat autoinflammatory disease
REGENERON PHARMA10 citations82
US7410781B2Aug 12, 2008
IL-4/IL-13 specific polypeptides and therapeutic uses thereof
REGENERON PHARMA10 citations80
US11950578B2Apr 9, 2024
ADAM6 mice
REGENERON PHARMA2 citations73
US11666040B2Jun 6, 2023
Humanized non-human animals with restricted immunoglobulin heavy chain loci
REGENERON PHARMA3 citations73
US11370843B2Jun 28, 2022
High affinity antibodies to human IL-6 receptor
REGENERON PHARMA1 citations73
US10584364B2Mar 10, 2020
Mice that produce hybrid antibodies
REGENERON PHARMA1 citations73
US7361350B2Apr 22, 2008
Use of an IL-1 antagonist for treating arthritis
REGENERON PHARMA6 citations70
MURPHY ANDREW J
3 patentsUS8502018B2Aug 6, 2013
Methods of modifying eukaryotic cells
MURPHY ANDREW J250 citations99
US8791323B2Jul 29, 2014
Hybrid antibodies comprising human variable regions and mouse constant regions produced in a genetically modified mouse
MURPHY ANDREW J97 citations98
US9376699B2Jun 28, 2016
Methods of producing hybrid antibodies
MURPHY ANDREW J4 citations84
AMGEN INC
3 patentsUS9580486B2Feb 28, 2017
Interleukin-2 muteins for the expansion of T-regulatory cells
AMGEN INC47 citations96
US9932380B2Apr 3, 2018
Interleukin-2 muteins for the expansion of T-regulatory cells
AMGEN INC23 citations93
US10829535B2Nov 10, 2020
Interleukin-2 muteins for the expansion of T-regulatory cells
AMGEN INC5 citations83
RADIN ALLEN
3 patentsUS8568721B2Oct 29, 2013
Method of treating rheumatoid arthritis with an anti-IL-6R antibody
RADIN ALLEN18 citations92
US8192741B2Jun 5, 2012
Method of treating rheumatoid arthritis with an anti-IL-6R antibody
RADIN ALLEN22 citations92
US8080248B2Dec 20, 2011
Method of treating rheumatoid arthritis with an IL-6R antibody
RADIN ALLEN15 citations92
GENSUN BIOPHARMA INC
3 patentsMCWHIRTER JOHN
1 patentSTEVENS SEAN
1 patentXILIO DEV INC
1 patentREGENERAN PHARMACEUTICALS INC
1 patentShowing the top 50 of 74 patents by PatentIndex Score.